Testing effectiveness (Phase 2)WithdrawnNCT00578591What this trial is testingRituximab for GVHDWho this might be right forGraft vs Host DiseaseAlogenic Hematopoietic Transplant Baylor College of Medicine
Post-approval studies (Phase 4)Active Not RecruitingNCT06462469What this trial is testingStudy of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host DiseaseWho this might be right forSteroid-refractory Acute Graft Versus Host Disease Novartis Pharmaceuticals 36
Not applicableUnknownNCT04622475What this trial is testingEfficacy and Safety of FMT Capsule Treating Steroid-refractory GI-aGvHDWho this might be right forSteroid-refractory Gastrointestinal Acute Graft Versus Host Disease Nanfang Hospital, Southern Medical University 10
Testing effectiveness (Phase 2)Looking for participantsNCT05327023What this trial is testingDonor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic MalignanciesWho this might be right forHematologic Neoplasms National Cancer Institute (NCI) 430
Testing effectiveness (Phase 2)Study completedNCT02997280What this trial is testingRuxolitinib for Steroid-refractory GVHDWho this might be right forGraft Vs Host Disease St. Petersburg State Pavlov Medical University 75
Early research (Phase 1)Temporarily pausedNCT05993611What this trial is testingAllogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell TransplantationWho this might be right forChronic Graft Versus Host DiseaseHematologic and Lymphocytic DisorderSteroid Refractory Graft Versus Host Disease City of Hope Medical Center 27
Early research (Phase 1)Study completedNCT03683498What this trial is testingDonor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-host-DiseaseWho this might be right forChronic Graft vs Host Disease Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 16
Testing effectiveness (Phase 2)Study completedNCT02841995What this trial is testingEvaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host DiseaseWho this might be right forGraft vs Host Disease Kadmon, a Sanofi Company 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075225What this trial is testingMAP-guided Preemptive Therapy of aGvHD by RuxolitinibWho this might be right forGVHDAcute Stem Cell Transplant Complications Sichuan University 62
Testing effectiveness (Phase 2)Study completedNCT03491215What this trial is testingStudy of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host DiseaseWho this might be right forAcute Graft Versus Host Disease Novartis Pharmaceuticals 45
Testing effectiveness (Phase 2)Ended earlyNCT00409695What this trial is testingThymoglobulin (ATG) Dose Finding StudyWho this might be right forGraft vs Host Disease M.D. Anderson Cancer Center 1
Large-scale testing (Phase 3)Active Not RecruitingNCT04769895What this trial is testingMaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD PatientsWho this might be right forAcute Graft Versus Host Disease in IntestineSteroid Refractory GVHD MaaT Pharma 66
Post-approval studies (Phase 4)Study completedNCT00574470What this trial is testingAnti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHDWho this might be right forGraft vs Host Disease University of Iowa 3
Testing effectiveness (Phase 2)Study completedNCT04926194What this trial is testingDecidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative NeoplasmWho this might be right forMyelodysplastic/Myeloproliferative NeoplasmSteroid Refractory GVHDAllogeneic Hematopoietic Cell Transplant University Health Network, Toronto 1
Testing effectiveness (Phase 2)Looking for participantsNCT07572669What this trial is testingMoxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forSteroid-Refractory Acute Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseGraft-Versus-Host Disease+1 more Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 42
Testing effectiveness (Phase 2)UnknownNCT01549665What this trial is testingUmbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-diseaseWho this might be right forGraft-Versus-Host DiseaseGVHDAllogeneic Hematopoietic Transplant+1 more Samsung Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT03359980What this trial is testingTreatment of Steroid Refractory Gastro-intestinal Acute GVHD afteR AllogeneiC HSCT With fEcal Microbiota tranSferWho this might be right forFecal Microbiota Transplantation MaaT Pharma 24
Testing effectiveness (Phase 2)Ended earlyNCT01475162What this trial is testingTocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host DiseaseWho this might be right forAcute Graft Versus Host Disease Medical College of Wisconsin 14
Testing effectiveness (Phase 2)UnknownNCT00314483What this trial is testingEvaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host DiseaseWho this might be right forGraft vs Host Disease Christian Medical College, Vellore, India 25
Testing effectiveness (Phase 2)Ended earlyNCT01226420What this trial is testingAlefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host DiseaseWho this might be right forChronic Graft-versus-host Disease Dana-Farber Cancer Institute 6